William Blair

Selected news for the capital firm - William Blair, collected since 10/2017. Recent stories appear in slatersentinel.com. This capital firm shares healthcare news with Medical Research, CRISPR, Henry Schein, Fitbit, Amedisys and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/8/2021 William Blair Weighs in on Lucira Health, Inc.'s Q1 2021 Earnings (NASDAQ:LHDX) dispatchtribunal.com US Crude Prices Plummet 4% as Russia and OPEC Consider Easing CapsLucira Health, Inc. (NASDAQ:LHDX) – Stock analysts at William Blair raised their Q1 2021 EPS estimates for shares of Lucira Health in a report issued on Tuesday, May 4th. William Blair analyst B. Weinstein now forecasts that the company will earn ($0.27) per share for the quarter, up from their previous estimate of ($0.39). William Blair currently ...
5/8/2021 William Blair Weighs in on PTC Therapeutics, Inc.'s Q2 2021 Earnings (NASDAQ:PTCT) - WKRB News wkrb13.com PTC Therapeutics, Inc. (NASDAQ:PTCT) – Equities research analysts at William Blair dropped their Q2 2021 EPS estimates for shares of PTC Therapeutics in a note issued to investors on Tuesday, May 4th. William Blair analyst R. Prasad now forecasts that the biopharmaceutical company will post earnings of ($2.06) per share for the quarter, down from their previous estimate of ($1.93). William Blair also issued estimates for PTC Therapeutics’ ...
5/8/2021 Cellectis (NASDAQ:CLLS) Trading Up 7.4% on Earnings Beat - Watch List News watchlistnews.com ... Cellectis alerts: Several research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Cellectis from a “hold” rating to a “sell” rating in a research report on Wednesday. William Blair reaffirmed an “outperform” rating on shares of Cellectis in a research note on Monday, March 8th. Robert W. Baird reiterated a “buy” rating and set a $39.00 price objective on shares of ...
5/8/2021 Xenon Pharmaceuticals (NASDAQ:XENE) Downgraded to Sell at Zacks Investment Research baseballnewssource.com ... the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada. “ Get Xenon Pharmaceuticals alerts:Other equities research analysts have also issued research reports about the company. William Blair restated a buy rating on shares of Xenon Pharmaceuticals in a research report on Friday, March 5th. Needham & Company LLC upped their target price on Xenon Pharmaceuticals from $22.00 to $25.00 and gave the ...
5/8/2021 Zacks Investment Research Downgrades Yext (NYSE:YEXT) to Sell dispatchtribunal.com ... issued reports on YEXT. Morgan Stanley cut their price target on shares of Yext from $14.00 to $13.00 and set an underweight rating on the stock in a research note on Wednesday, March 10th. William Blair reaffirmed a market perform rating on shares of Yext in a report on Wednesday, March 10th. Truist dropped their price objective on shares of Yext from $23.00 to $17.00 in a report on Thursday ...
5/7/2021 Alignment Healthcare (NASDAQ:ALHC) Trading Down 6.5% baseballnewssource.com ... on ALHC shares. The Goldman Sachs Group started coverage on Alignment Healthcare in a research report on Monday, April 26th. They issued a “neutral” rating and a $25.00 target price on the stock. William Blair assumed coverage on shares of Alignment Healthcare in a research note on Monday, April 26th. They issued an “outperform” rating for the company. Raymond James assumed coverage on shares of Alignment Healthcare in ...
5/7/2021 Huron Consulting Group Inc. to Post Q2 2021 Earnings of $0.42 Per Share, William Blair Forecasts (NASDAQ:HURN) - WKRB News wkrb13.com Huron Consulting Group Inc. (NASDAQ:HURN) – Stock analysts at William Blair reduced their Q2 2021 earnings estimates for Huron Consulting Group in a research note issued on Wednesday, May 5th. William Blair analyst A. Nicholas now forecasts that the business services provider will earn $0.42 per share for the quarter, down from their previous estimate of $0.44. William Blair also issued estimates for Huron Consulting Group’s Q3 2021 ...
5/7/2021 William Blair Analysts Cut Earnings Estimates for Huron Consulting Group Inc. (NASDAQ:HURN) zolmax.com William Blair Analysts Cut Earnings Estimates for Huron Consulting Group Inc. (NASDAQ:HURN) Posted by Alphonse Anthony on May 7th, 2021 TweetHuron Consulting Group Inc. (NASDAQ:HURN) – William Blair cut their Q2 2021 EPS estimates for Huron Consulting Group in a research report issued on Wednesday, May 5th. William Blair analyst A. Nicholas now anticipates that the business services provider will post earnings of $0.42 per share for ...
5/7/2021 GoDaddy Inc. (GDDY) Q1 2021 Earnings Call Transcript alphastreet.com ... Äî Barclays ‚Äî Analyst Ron Josey ‚Äî JMP Securities ‚Äî Analyst Clarke Jeffries ‚Äî Piper Sandler ‚Äî Analyst Ygal Arounian ‚Äî Wedbush Securities ‚Äî Analyst Brent Thill ‚Äî Jefferies ‚Äî Analyst Matthew Pfau ‚Äî William Blair ‚Äî Analyst Naved Khan ‚Äî Truist ‚Äî Analyst Frank Volpe ‚Äî Wolfe Research ‚Äî Analyst Mark Grant ‚Äî Vice President of Investor Relations Good afternoon and thank you for joining us for GoDaddy‚Äôs ...
5/7/2021 HubSpot Inc. (HUBS) Q1 2021 Earnings Call Transcript alphastreet.com ... Wolfe Research — Analyst Stan Zlotsky — Morgan Stanley — Analyst Mark Murphy — JPMorgan — Analyst DJ Hynes — Canaccord Genuity — Analyst Brad Sills — BofA Securities — Analyst Arjun Bhatia — William Blair — Analyst Alex Henderson — Needham & Company — Analyst Terry Tillman — Truist Securities — Analyst Parker Lane — Stifel — Analyst Chris Merwin — Goldman Sachs — Analyst Ken Wong — Guggenheim Securities ...
5/7/2021 Premier (NASDAQ:PINC) Rating Increased to Buy at Zacks Investment Research | Daily Political Daily Political William Blair Weighs in on Xilinx, Inc.’s Q1 2022 Earnings (NASDAQ:XLNX) Premier (NASDAQ:PINC) Rating Increased to Buy at Zacks Investment Research Premier (NASDAQ:PINC) Rating Increased to Buy at Zacks Investment Research - Filed Under - by Latisha Jones TweetPremier (NASDAQ:PINC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on ...
5/7/2021 ExlService (NASDAQ:EXLS) Downgraded to “Hold” at Zacks Investment Research - Ticker Report Ticker Report ... gave the stock a neutral rating in a research report on Monday, March 8th. Robert W. Baird reissued a hold rating on shares of ExlService in a research report on Sunday, February 28th. Finally, William Blair reaffirmed an outperform rating on shares of ExlService in a report on Thursday, February 25th. Six analysts have rated the stock with a hold rating and three have given a buy rating to the ...
5/7/2021 Yext (NYSE:YEXT) Stock Rating Lowered by Zacks Investment Research - Watch List News watchlistnews.com ... the company a “buy” rating in a research report on Wednesday, March 24th. Truist lowered their price target on Yext from $23.00 to $17.00 in a research report on Thursday, March 4th. Finally, William Blair reaffirmed a “market perform” rating on shares of Yext in a research report on Wednesday, March 10th. Two investment analysts have rated the stock with a sell rating, two have issued a hold ...
5/7/2021 Encompass Health to participate in the William Blair Annual Growth Stock Conference and Jefferies Virtual Healthcare Conference Yahoo News BIRMINGHAM, Ala. , May 7, 2021 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in William Blair's 41st Annual Growth Stock Conference and Jefferies Virtual Healthcare Conference. Both conferences will be held virtually the first week of June 2021 .(PRNewsfoto/Encompass Health Corporation) Encompass Health's President and Chief Executive Officer Mark Tarr , EVP and Chief Financial Officer Doug Coltharp , and EVP and President of Inpatient Hospitals Barb Jacobsmeyer ...
5/5/2021 Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Quiet Period Will Expire on May 5th rivertonroll.com ... objective for the company. Raymond James started coverage on shares of Alignment Healthcare in a report on Monday, April 26th. They set an “outperform” rating and a $30.00 price target for the company. William Blair initiated coverage on Alignment Healthcare in a research note on Monday, April 26th. They issued an “outperform” rating on the stock. UBS Group initiated coverage on Alignment Healthcare in a research report on ...
5/5/2021 Alteryx, Inc. (AYX) Q1 2021 Earnings Call Transcript alphastreet.com ... Analyst Jack Andrews — Needham & Company LLC — Analyst Pinjalim Bora — J.P. Morgan — Analyst Derrick Wood — Cowen & Company — Analyst Steven Koenig — SMBC Nikko Securities — Analyst Bhavan Suri — William Blair — Analyst Pat Walravens — JMP Securities — Analyst Christopher Merwin — Goldman Sachs — Analyst Operator Greetings and welcome to Alteryx First Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this ...
5/5/2021 Oppenheimer Sticks to Their Buy Rating for Incyte (INCY) markets.co ... word on The Street in general, suggests a Moderate Buy analyst consensus rating for Incyte with a $99.14 average price target, a 18.7% upside from current levels. In a report issued on April 26, William Blair also reiterated a Buy rating on the stock.See today’s analyst top recommended stocks
Based on Incyte’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue ...
5/4/2021 William Blair Comments on Amgen Inc.'s Q2 2021 Earnings (NASDAQ:AMGN) - WKRB News wkrb13.com Amgen Inc. (NASDAQ:AMGN) – Analysts at William Blair cut their Q2 2021 earnings per share estimates for Amgen in a research note issued on Wednesday, April 28th. William Blair analyst M. Phipps now expects that the medical research company will post earnings per share of $3.90 for the quarter, down from their prior estimate of $4.42. William Blair also issued estimates for Amgen’s Q2 2022 earnings at $3.79 ...
5/4/2021 Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Quiet Period Will End Tomorrow slatersentinel.com ... price objective on the stock. Piper Sandler began coverage on Alignment Healthcare in a research note on Monday, April 26th. They issued an “overweight” rating and a $30.00 price target for the company. William Blair assumed coverage on shares of Alignment Healthcare in a research note on Monday, April 26th. They issued an “outperform” rating on the stock. Bank of America initiated coverage on shares of Alignment Healthcare ...
5/4/2021 Q2 2021 EPS Estimates for Teladoc Health, Inc. (NYSE:TDOC) Raised by Analyst dispatchtribunal.com US Crude Prices Plummet 4% as Russia and OPEC Consider Easing CapsTeladoc Health, Inc. (NYSE:TDOC) – Stock analysts at William Blair increased their Q2 2021 earnings per share (EPS) estimates for Teladoc Health in a note issued to investors on Wednesday, April 28th. William Blair analyst R. Daniels now forecasts that the health services provider will post earnings of ($0.36) per share for the quarter, up from their ...